Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting

Journal of the American College of Cardiology

Volumn 35, Issue 5, 2000, Pages 1134-1141

  Saucedo, Jorge F ^a   Mehran, Roxana ^b   Dangas, George ^b   Hong, Mun K ^b   Lansky, Alexandra ^b   Kent, Kenneth M ^b   Satler, Lowell F ^b   Pichard, Augusto D ^b   Stone, Gregg W ^b   Leon, Martin B ^b  

^a Depts Int Med (Cardiol D   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; ISOENZYME;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY STENT; CREATINE KINASE BLOOD LEVEL; DEATH; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANTATION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; TREATMENT OUTCOME;

AGED; ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY DISEASE; CREATINE KINASE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY EDEMA; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STENTS; TREATMENT OUTCOME;

EID: 0034074535     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00513-1     Document Type: Article

References (26)

1. Harrington R.A., Lincoff M.A., Califf R.M., et al. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention insights from the coronary angioplasty versus excisional atherectomy trial (CAVEAT) . J Am Coll Cardiol. 25:1995;1693-1699.
2. Hunt A.C., Chow S.L., Shiu M.F., Chilton D.C., Cummins B., Cummins P. Release of creatine kinase-MB and cardiac specific troponin-I following percutaneous transluminal coronary angioplasty. Eur Heart J. 12:1991;690-693.
3. Popma J.J., Leon M.B. A lesion-specific approach to new-device angioplasty. Topol E.J. Textbook of Interventional Cardiology. 2nd ed. 1994;973-985 Saunders, Philadelphia.
4. Cutlip D.E., Baim D.S., Senerchia C., et al. Clinical consequences of myocardial infarction following balloon angioplasty or directional coronary atherectomy acute and 1-year results of the balloon vs. optimal atherectomy trial (BOAT) . (abstr) J Am Coll Cardiol. 29:(suppl A):1997;187A.
5. Pauletto P., Piccolo D., Scannapieco G., et al. Changes in myoglobin, creatine kinase and creatine kinase-MB after percutaneous transluminal coronary angioplasty for stable angina pectoris. Am J Cardiol. 59:1987;999-1000.
6. Spadaro J.J., Ludbrook P.A., Tiefenbrunn A.J., Kurnik P.B., Jaffe A.S. Paucity of subtle myocardial injury after angioplasty delineated with MB CK. Cathet Cardiovasc Diagn. 12:1986;230-234.
7. Oh J.K., Shub C., Ilstrup D.M., Reeder G.S. Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J. 109:1985;1225-1231.
8. Klein L.W., Kramer B.L., Howard E., Lesch M. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q-wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol. 17:1991;621-626.
9. Ravkilde J., Nissen H., Mickley H., Anderson P.E., Thayssen P., Horder M. Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J. 127:1994;13-20.
10. Hong M.K., Bucher T.A., Wu H., Weaver T., Morgan K., Satler L.F. CPK-MB elevation following successful saphenous vein graft angioplasty is associated with increased late mortality. (abstr) Circulation. 96:(suppl I):1997;I31.
11. Abdelmeguid A.E., Ellis S.G., Sapp S.K., Whitlow P.L., Topol E.J. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. Am Heart J. 131:1996;1097-1105.
12. Abdelmeguid A.E., Topol E.J., Whitlow P.L., Sapp S.K., Ellis S.G. Significance of mild transient release of creatine kinase-MB fraction after percutaneous interventions. Circulation. 94:1996;1528-1536.
13. Kugelmass A.D., Cohen D.J., Moscucci M., et al. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol. 74:1994;748-754.
14. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina the CAPTURE study . Lancet. 349:1997;1429-1435.
15. Platelet glycoprotein IIb/IIIa receptor blockade and low dose heparin during percutaneous coronary revascularization. N Engl J Med. 336:1997;1689-1696.
16. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention IMPACT-II . Lancet. 349:1997;1422-1428.
17. Kong T.Q., Davidson C.J., Meyers S.N., Tauke J.T., Parker M.A., Bonow R.O. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA. 277:1997;461-466.
18. Elliot J.M., Berdan L.G., Holmes D.R., et al. One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I). Circulation. 91:1995;2158-2166.
19. Tardiff B.E., Califf R.M., Tcheng J.E., et al. Post-intervention cardiac enzyme elevation prognostic significance in IMPACT II. J Am Coll Cardiol. 33:1999;88-96.
20. Cutlip D.E., Chauhan M., Lasorda D., et al. Influence of post-procedural myocardial infarction on late clinical outcome in the Stent Anti-Thrombotic Regimen Study (STARS). (abstr) Circulation. 96:(suppl I):1997;I31.
21. Cutlip D.E., Chauhan M., Senerchia C., Ho K.K., Baim D.S., Kuntz R.E. Influence of myocardial infarction following otherwise successful coronary intervention on late mortality. (abstr) Circulation. 96:(suppl 1):1997;I30.
22. Hodakowski G.T., Craver J.M., Jones E.L., King S.B. III, Guyton R.A. Clinical significance of perioperative Q-wave myocardial infarction the Emory Angioplasty versus Surgery Trial . J Thorac Cardiovasc Surg. 112:1996;1447-1454.
23. Lim R., Zawacki K., Laskey W.K. Creatine kinase release after catheter-based coronary intervention. Cathet Cardiovasc Diagn. 41:1997;117-119.
24. Ohman E.M., Tardiff B.E. Periprocedural cardiac marker elevation after percutaneous coronary artery revascularization. JAMA. 277:1997;495-497.
25. Saucedo J.F., Talley J.D., Kennard E.D., et al. Predictors of long-term clinical events in the new approaches to coronary intervention (NACI) Registry. (abstr) Circulation. 98:(suppl I):1998;I443.
26. Peterson E.D., Lansky A.J., Muhlbaier L.H., et al. Evolving trends in angioplasty device selection a national cardiovascular network (NCN) database report . (abstr) J Am Coll Cardiol. 29:(suppl A):1997;495A.